Julie Eskay-Eagle is the Managing Director at September Ventures LLC.
Eskay-Eagle was a full time employee of The Wellcome Trust in London, UK from 2001-2004 where she established a formal Direct Investment Program. Prior to joining the Trust she was a Vice President with Lazard Freres in Health Care Investment Banking and a founding member of Lazard Technology Partners.
Before joining Lazard, Eskay-Eagle was a Health Care Specialist with McKinsey & Co. in New York.
Julie Eskay-Eagle has a bachelor's degree in Biomedical Ethics from Cornell University and an MBA from Columbia University.
It's not that long because the venture capitalists know they need to be able to come back to us in a reasonable time and say they've generated a return. One way they do that is they look for opportunities where there is a little bit of a leapfrog in the investment. So, it might be a new molecule, ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
Julie Eskay-Eagle States Importance of Finding Out What Excites You And What You Do Well And Pursuing That As A Profession
Julie Eskay-Eagle Provides Outline of Due Diligence Process Prior To Firm Making Investment
Julie Eskay-Eagle States Venture Capitalists Are Generally Looking For Shorter Project Timeframes
Julie Eskay-Eagle Discusses Outlook For Investment In Healthcare And Pharmaceutical Industries
